Developing the Short-Form of Lymphedema Needs Questionnaire for Iranian Breast Cancer Patients
- PMID: 40152083
- PMCID: PMC11950831
- DOI: 10.1002/cam4.70832
Developing the Short-Form of Lymphedema Needs Questionnaire for Iranian Breast Cancer Patients
Abstract
Purpose: The informational needs of patients with Breast Cancer-Related Lymphedema (BCRL) have not been sufficiently addressed in the scientific literature. Moreover, the only existing questionnaire in this field contains many items. Therefore, the purpose of this study is to develop a short-form version of this questionnaire.
Methods: The questionnaire items were extracted from the Lymphoedema Needs Questionnaire-Breast Cancer (LNQ-BC). Demographic variables and clinical characteristics were considered separately. Out of 62 items, 24 were selected, and 2 additional questions were included based on feedback from 10 experts. 100 participants with BCRL completed the short-form questionnaire. Exploratory Factor Analysis (EFA) was performed using principal components extraction and varimax rotation, and Cronbach's alpha was calculated for each dimension.
Results: After evaluating the content validity, the instrument's construct validity with 26 items was conducted using EFA. The KMO (Kaiser-Meyer-Olkin) value was equal to 0.879 and Bartlett's sphericity test was significant (p-value < 0.001), indicating the data's adequacy and appropriateness to perform EFA. Five extracted dimensions were named: "Lymphedema information needs" (5 items), "Informational support, peers" (5 items), "Access to a lymphedema care specialist" (5 items), "Physical and daily activities" (7 items) and "Financial issues and compression garments" (4 items). The level of needs in this study in all dimensions was high (more than 77%).
Conclusions: The high factor loadings and the total explained variance of 78.152% support the construct validity of the short questionnaire. Although some items exhibited cross-loadings, the majority loaded strongly on a single factor, indicating good discriminant validity. Providing services according to the needs of patients can be prioritized. Healthcare providers, insurers, and individuals should be better informed about lymphedema, its associated costs, and the importance of implementing appropriate management programs.
Keywords: breast cancer; breast cancer‐related lymphedema (BCRL); exploratory factor analysis (EFA); informational needs; lymphedema management; needs assessment; patient‐centered care; questionnaire development; short‐form questionnaire.
© 2025 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Psychometric Evaluation of the Bahasa Malaysia Version of the Lymphedema Functioning, Disability, and Health Questionnaire for Upper Limb Lymphedema in Patients with Breast Cancer-Related Lymphedema.Lymphat Res Biol. 2024 Jun;22(3):210-220. doi: 10.1089/lrb.2023.0045. Epub 2024 Apr 12. Lymphat Res Biol. 2024. PMID: 38608242
-
Psychometric Validation of the Chinese Version of the Lymphedema Functioning, Disability, and Health Questionnaire for Upper Limb Lymphedema in Patients With Breast Cancer-Related Lymphedema.Cancer Nurs. 2022 Jan-Feb 01;45(1):70-82. doi: 10.1097/NCC.0000000000000848. Cancer Nurs. 2022. PMID: 32541206
-
The Reliability and Validity of the Turkish Version of the Lymphedema Life Impact Scale in Patients With Breast Cancer-Related Lymphedema.Cancer Nurs. 2020 Sep/Oct;43(5):375-383. doi: 10.1097/NCC.0000000000000709. Cancer Nurs. 2020. PMID: 30921030
-
Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.Breast Cancer Res Treat. 2023 Feb;198(1):1-9. doi: 10.1007/s10549-022-06850-7. Epub 2022 Dec 24. Breast Cancer Res Treat. 2023. PMID: 36566297 Free PMC article. Review.
-
Advances in the prevention and treatment of breast cancer-related lymphedema.Breast Cancer Res Treat. 2023 Jul;200(1):1-14. doi: 10.1007/s10549-023-06947-7. Epub 2023 Apr 27. Breast Cancer Res Treat. 2023. PMID: 37103598 Free PMC article. Review.
References
-
- Sung H., Ferlay J., Siegel R. L., et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 71, no. 3 (2021): 209–249. - PubMed
-
- Kazeminia M., Salari N., Hosseinian‐Far A., Akbari H., Bazrafshan M. R., and Mohammadi M., “The Prevalence of Breast Cancer in Iranian Women: A Systematic Review and Meta‐Analysis,” Indian Journal of Gynecologic Oncology 20, no. 1 (2022): 14.
-
- Rahimzadeh M., Pourhoseingholi M. A., and Kavehie B., “Survival Rates for Breast Cancer in Iranian Patients: A Meta‐Analysis,” Asian Pacific Journal of Cancer Prevention 17, no. 4 (2016): 2223–2227. - PubMed
-
- Committee, N.L.N.M.A , “Position Statement of the National Lymphedema Network,” 2012.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical